zotatifin
effector therapeutics
['eft226', 'zotatifin', 'effector therapeutics', '$eftr']
$eftr - effector therapeutics reports positive interim results in zotatifin (eft226) phase 1/2 clinical trial at asco 2022 showing safety and tolerability, and initial signals of clinical activity
The information in these Market Commentaries do not constitute a solicitation of the purchase or sale of any stocks ,  or options contracts.